ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Genotyping Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-6J7443
Home | Market Reports | Science| Biological Sciences
Global Genotyping Market Insights and Forecast to 2028
BUY CHAPTERS

Global Genotyping Market Research Report 2025

Code: QYRE-Auto-6J7443
Report
August 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Illumina Inc
Affymetrix Inc
Life Technologies
Agilent Technologies
Qiagen NV
Sequenom
Fluidigm
Beckman Coulter
Roche
GE Healthcare

Genotyping Market Size

The global market for Genotyping was valued at US$ 16250 million in the year 2024 and is projected to reach a revised size of US$ 34250 million by 2031, growing at a CAGR of 11.4% during the forecast period.

Genotyping Market

Genotyping Market

Genotyping is used to study genetic variation in the genotypes of living organisms, including humans, animals, plants, and microorganisms.
Developed regions like North America and Europe will grow comparatively slower than emerging markets like Asia-Pacific and RoW (Latin America).

Report Scope

This report aims to provide a comprehensive presentation of the global market for Genotyping, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genotyping.
The Genotyping market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genotyping market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genotyping manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Genotyping Market Report

Report Metric Details
Report Name Genotyping Market
Accounted market size in year US$ 16250 million
Forecasted market size in 2031 US$ 34250 million
CAGR 11.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Polymerase Chain Reaction
  • Sequencing
  • Microarray
  • Electrophoresis
  • MALDI-TOF
Segment by Application
  • Pharmacogenomics
  • Diagnostic Research
  • Animal Genetics
  • Agricultural Biotechnology
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Illumina, Affymetrix, Life Technologies, Agilent Technologies, Qiagen, Sequenom, Fluidigm, Beckman Coulter, Roche, GE Healthcare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Genotyping manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Genotyping in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Genotyping Market growing?

Ans: The Genotyping Market witnessing a CAGR of 11.4% during the forecast period 2025-2031.

What is the Genotyping Market size in 2031?

Ans: The Genotyping Market size in 2031 will be US$ 34250 million.

Who are the main players in the Genotyping Market report?

Ans: The main players in the Genotyping Market are Illumina, Affymetrix, Life Technologies, Agilent Technologies, Qiagen, Sequenom, Fluidigm, Beckman Coulter, Roche, GE Healthcare

What are the Application segmentation covered in the Genotyping Market report?

Ans: The Applications covered in the Genotyping Market report are Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology

What are the Type segmentation covered in the Genotyping Market report?

Ans: The Types covered in the Genotyping Market report are Polymerase Chain Reaction, Sequencing, Microarray, Electrophoresis, MALDI-TOF

1 Genotyping Market Overview
1.1 Product Definition
1.2 Genotyping by Type
1.2.1 Global Genotyping Market Value Comparison by Type (2024 VS 2031)
1.2.2 Polymerase Chain Reaction
1.2.3 Sequencing
1.2.4 Microarray
1.2.5 Electrophoresis
1.2.6 MALDI-TOF
1.3 Genotyping by Application
1.3.1 Global Genotyping Market Value by Application (2024 VS 2031)
1.3.2 Pharmacogenomics
1.3.3 Diagnostic Research
1.3.4 Animal Genetics
1.3.5 Agricultural Biotechnology
1.4 Global Genotyping Market Size Estimates and Forecasts
1.4.1 Global Genotyping Revenue 2020-2031
1.4.2 Global Genotyping Sales 2020-2031
1.4.3 Global Genotyping Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Genotyping Market Competition by Manufacturers
2.1 Global Genotyping Sales Market Share by Manufacturers (2020-2025)
2.2 Global Genotyping Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Genotyping Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Genotyping, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Genotyping, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genotyping, Product Type & Application
2.7 Global Key Manufacturers of Genotyping, Date of Enter into This Industry
2.8 Global Genotyping Market Competitive Situation and Trends
2.8.1 Global Genotyping Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Genotyping Players Market Share by Revenue
2.8.3 Global Genotyping Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Genotyping Market Scenario by Region
3.1 Global Genotyping Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Genotyping Sales by Region: 2020-2031
3.2.1 Global Genotyping Sales by Region: 2020-2025
3.2.2 Global Genotyping Sales by Region: 2026-2031
3.3 Global Genotyping Revenue by Region: 2020-2031
3.3.1 Global Genotyping Revenue by Region: 2020-2025
3.3.2 Global Genotyping Revenue by Region: 2026-2031
3.4 North America Genotyping Market Facts & Figures by Country
3.4.1 North America Genotyping Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Genotyping Sales by Country (2020-2031)
3.4.3 North America Genotyping Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Genotyping Market Facts & Figures by Country
3.5.1 Europe Genotyping Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Genotyping Sales by Country (2020-2031)
3.5.3 Europe Genotyping Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Genotyping Market Facts & Figures by Region
3.6.1 Asia Pacific Genotyping Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Genotyping Sales by Region (2020-2031)
3.6.3 Asia Pacific Genotyping Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Genotyping Market Facts & Figures by Country
3.7.1 Latin America Genotyping Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Genotyping Sales by Country (2020-2031)
3.7.3 Latin America Genotyping Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Genotyping Market Facts & Figures by Country
3.8.1 Middle East and Africa Genotyping Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Genotyping Sales by Country (2020-2031)
3.8.3 Middle East and Africa Genotyping Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Genotyping Sales by Type (2020-2031)
4.1.1 Global Genotyping Sales by Type (2020-2025)
4.1.2 Global Genotyping Sales by Type (2026-2031)
4.1.3 Global Genotyping Sales Market Share by Type (2020-2031)
4.2 Global Genotyping Revenue by Type (2020-2031)
4.2.1 Global Genotyping Revenue by Type (2020-2025)
4.2.2 Global Genotyping Revenue by Type (2026-2031)
4.2.3 Global Genotyping Revenue Market Share by Type (2020-2031)
4.3 Global Genotyping Price by Type (2020-2031)
5 Segment by Application
5.1 Global Genotyping Sales by Application (2020-2031)
5.1.1 Global Genotyping Sales by Application (2020-2025)
5.1.2 Global Genotyping Sales by Application (2026-2031)
5.1.3 Global Genotyping Sales Market Share by Application (2020-2031)
5.2 Global Genotyping Revenue by Application (2020-2031)
5.2.1 Global Genotyping Revenue by Application (2020-2025)
5.2.2 Global Genotyping Revenue by Application (2026-2031)
5.2.3 Global Genotyping Revenue Market Share by Application (2020-2031)
5.3 Global Genotyping Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Illumina
6.1.1 Illumina Company Information
6.1.2 Illumina Description and Business Overview
6.1.3 Illumina Genotyping Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Illumina Genotyping Product Portfolio
6.1.5 Illumina Recent Developments/Updates
6.2 Affymetrix
6.2.1 Affymetrix Company Information
6.2.2 Affymetrix Description and Business Overview
6.2.3 Affymetrix Genotyping Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Affymetrix Genotyping Product Portfolio
6.2.5 Affymetrix Recent Developments/Updates
6.3 Life Technologies
6.3.1 Life Technologies Company Information
6.3.2 Life Technologies Description and Business Overview
6.3.3 Life Technologies Genotyping Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Life Technologies Genotyping Product Portfolio
6.3.5 Life Technologies Recent Developments/Updates
6.4 Agilent Technologies
6.4.1 Agilent Technologies Company Information
6.4.2 Agilent Technologies Description and Business Overview
6.4.3 Agilent Technologies Genotyping Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Agilent Technologies Genotyping Product Portfolio
6.4.5 Agilent Technologies Recent Developments/Updates
6.5 Qiagen
6.5.1 Qiagen Company Information
6.5.2 Qiagen Description and Business Overview
6.5.3 Qiagen Genotyping Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Qiagen Genotyping Product Portfolio
6.5.5 Qiagen Recent Developments/Updates
6.6 Sequenom
6.6.1 Sequenom Company Information
6.6.2 Sequenom Description and Business Overview
6.6.3 Sequenom Genotyping Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sequenom Genotyping Product Portfolio
6.6.5 Sequenom Recent Developments/Updates
6.7 Fluidigm
6.7.1 Fluidigm Company Information
6.7.2 Fluidigm Description and Business Overview
6.7.3 Fluidigm Genotyping Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Fluidigm Genotyping Product Portfolio
6.7.5 Fluidigm Recent Developments/Updates
6.8 Beckman Coulter
6.8.1 Beckman Coulter Company Information
6.8.2 Beckman Coulter Description and Business Overview
6.8.3 Beckman Coulter Genotyping Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Beckman Coulter Genotyping Product Portfolio
6.8.5 Beckman Coulter Recent Developments/Updates
6.9 Roche
6.9.1 Roche Company Information
6.9.2 Roche Description and Business Overview
6.9.3 Roche Genotyping Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Roche Genotyping Product Portfolio
6.9.5 Roche Recent Developments/Updates
6.10 GE Healthcare
6.10.1 GE Healthcare Company Information
6.10.2 GE Healthcare Description and Business Overview
6.10.3 GE Healthcare Genotyping Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GE Healthcare Genotyping Product Portfolio
6.10.5 GE Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genotyping Industry Chain Analysis
7.2 Genotyping Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genotyping Production Mode & Process Analysis
7.4 Genotyping Sales and Marketing
7.4.1 Genotyping Sales Channels
7.4.2 Genotyping Distributors
7.5 Genotyping Customer Analysis
8 Genotyping Market Dynamics
8.1 Genotyping Industry Trends
8.2 Genotyping Market Drivers
8.3 Genotyping Market Challenges
8.4 Genotyping Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Illumina Inc
Affymetrix Inc
Life Technologies
Agilent Technologies
Qiagen NV
Sequenom
Fluidigm
Beckman Coulter
Roche
GE Healthcare
List of Tables
 Table 1. Global Genotyping Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Genotyping Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Genotyping Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Genotyping Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Genotyping Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Genotyping Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Genotyping Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Genotyping Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Genotyping, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Genotyping, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Genotyping, Product Type & Application
 Table 12. Global Key Manufacturers of Genotyping, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Genotyping by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genotyping as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Genotyping Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Genotyping Sales by Region (2020-2025) & (K Units)
 Table 18. Global Genotyping Sales Market Share by Region (2020-2025)
 Table 19. Global Genotyping Sales by Region (2026-2031) & (K Units)
 Table 20. Global Genotyping Sales Market Share by Region (2026-2031)
 Table 21. Global Genotyping Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Genotyping Revenue Market Share by Region (2020-2025)
 Table 23. Global Genotyping Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Genotyping Revenue Market Share by Region (2026-2031)
 Table 25. North America Genotyping Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Genotyping Sales by Country (2020-2025) & (K Units)
 Table 27. North America Genotyping Sales by Country (2026-2031) & (K Units)
 Table 28. North America Genotyping Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Genotyping Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Genotyping Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Genotyping Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Genotyping Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Genotyping Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Genotyping Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Genotyping Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Genotyping Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Genotyping Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Genotyping Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Genotyping Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Genotyping Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Genotyping Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Genotyping Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Genotyping Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Genotyping Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Genotyping Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Genotyping Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Genotyping Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Genotyping Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Genotyping Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Genotyping Sales (K Units) by Type (2020-2025)
 Table 51. Global Genotyping Sales (K Units) by Type (2026-2031)
 Table 52. Global Genotyping Sales Market Share by Type (2020-2025)
 Table 53. Global Genotyping Sales Market Share by Type (2026-2031)
 Table 54. Global Genotyping Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Genotyping Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Genotyping Revenue Market Share by Type (2020-2025)
 Table 57. Global Genotyping Revenue Market Share by Type (2026-2031)
 Table 58. Global Genotyping Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Genotyping Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Genotyping Sales (K Units) by Application (2020-2025)
 Table 61. Global Genotyping Sales (K Units) by Application (2026-2031)
 Table 62. Global Genotyping Sales Market Share by Application (2020-2025)
 Table 63. Global Genotyping Sales Market Share by Application (2026-2031)
 Table 64. Global Genotyping Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Genotyping Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Genotyping Revenue Market Share by Application (2020-2025)
 Table 67. Global Genotyping Revenue Market Share by Application (2026-2031)
 Table 68. Global Genotyping Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Genotyping Price (USD/Unit) by Application (2026-2031)
 Table 70. Illumina Company Information
 Table 71. Illumina Description and Business Overview
 Table 72. Illumina Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Illumina Genotyping Product
 Table 74. Illumina Recent Developments/Updates
 Table 75. Affymetrix Company Information
 Table 76. Affymetrix Description and Business Overview
 Table 77. Affymetrix Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Affymetrix Genotyping Product
 Table 79. Affymetrix Recent Developments/Updates
 Table 80. Life Technologies Company Information
 Table 81. Life Technologies Description and Business Overview
 Table 82. Life Technologies Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Life Technologies Genotyping Product
 Table 84. Life Technologies Recent Developments/Updates
 Table 85. Agilent Technologies Company Information
 Table 86. Agilent Technologies Description and Business Overview
 Table 87. Agilent Technologies Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Agilent Technologies Genotyping Product
 Table 89. Agilent Technologies Recent Developments/Updates
 Table 90. Qiagen Company Information
 Table 91. Qiagen Description and Business Overview
 Table 92. Qiagen Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Qiagen Genotyping Product
 Table 94. Qiagen Recent Developments/Updates
 Table 95. Sequenom Company Information
 Table 96. Sequenom Description and Business Overview
 Table 97. Sequenom Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Sequenom Genotyping Product
 Table 99. Sequenom Recent Developments/Updates
 Table 100. Fluidigm Company Information
 Table 101. Fluidigm Description and Business Overview
 Table 102. Fluidigm Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Fluidigm Genotyping Product
 Table 104. Fluidigm Recent Developments/Updates
 Table 105. Beckman Coulter Company Information
 Table 106. Beckman Coulter Description and Business Overview
 Table 107. Beckman Coulter Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Beckman Coulter Genotyping Product
 Table 109. Beckman Coulter Recent Developments/Updates
 Table 110. Roche Company Information
 Table 111. Roche Description and Business Overview
 Table 112. Roche Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Roche Genotyping Product
 Table 114. Roche Recent Developments/Updates
 Table 115. GE Healthcare Company Information
 Table 116. GE Healthcare Description and Business Overview
 Table 117. GE Healthcare Genotyping Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. GE Healthcare Genotyping Product
 Table 119. GE Healthcare Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Genotyping Distributors List
 Table 123. Genotyping Customers List
 Table 124. Genotyping Market Trends
 Table 125. Genotyping Market Drivers
 Table 126. Genotyping Market Challenges
 Table 127. Genotyping Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Genotyping
 Figure 2. Global Genotyping Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Genotyping Market Share by Type: 2024 & 2031
 Figure 4. Polymerase Chain Reaction Product Picture
 Figure 5. Sequencing Product Picture
 Figure 6. Microarray Product Picture
 Figure 7. Electrophoresis Product Picture
 Figure 8. MALDI-TOF Product Picture
 Figure 9. Global Genotyping Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Genotyping Market Share by Application: 2024 & 2031
 Figure 11. Pharmacogenomics
 Figure 12. Diagnostic Research
 Figure 13. Animal Genetics
 Figure 14. Agricultural Biotechnology
 Figure 15. Global Genotyping Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Genotyping Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Genotyping Sales (2020-2031) & (K Units)
 Figure 18. Global Genotyping Average Price (USD/Unit) & (2020-2031)
 Figure 19. Genotyping Report Years Considered
 Figure 20. Genotyping Sales Share by Manufacturers in 2024
 Figure 21. Global Genotyping Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Genotyping Players: Market Share by Revenue in Genotyping in 2024
 Figure 23. Genotyping Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Genotyping Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Genotyping Sales Market Share by Country (2020-2031)
 Figure 26. North America Genotyping Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Genotyping Sales Market Share by Country (2020-2031)
 Figure 30. Europe Genotyping Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Genotyping Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Genotyping Revenue Market Share by Region (2020-2031)
 Figure 38. China Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Genotyping Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Genotyping Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Genotyping Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Genotyping Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. UAE Genotyping Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Genotyping by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Genotyping by Type (2020-2031)
 Figure 60. Global Genotyping Price (USD/Unit) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Genotyping by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Genotyping by Application (2020-2031)
 Figure 63. Global Genotyping Price (USD/Unit) by Application (2020-2031)
 Figure 64. Genotyping Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions